Sanofi SA

Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer.
Quotes
- Bid
- Ask
- Open
- Previous close
- Volume
- Relative volume
- High
- Low
Returns
Key stats
ESG risk
ESG risk is a measure of how well a company manages material ESG risks. Sustainalytics’ ESG risk category is designed to help investors identify and understand financially material ESG risks at the company level and how they might affect the long-term performance for equity investments. The scale is from 0-100. The lower the risk, the better (0 is equivalent to no risk and 100 the most severe).
Download ESG risk methodology (PDF)Financials
About Sanofi SA
Sanofi develops and markets drugs with a concentration in immunology, vaccines, and rare diseases. Although the company offers a diverse array of drugs, its highest revenue generator, Dupixent, accounts for over 30% of total sales. Profits for this immunology blockbuster drug are shared with Regeneron. About 45% of total revenue comes from the United States, 20% from Europe, and 6% from China.
Frequently asked questions
To buy Sanofi SA stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for Sanofi SA by name or ticker, choose the number of shares, and place your order.
The ticker symbol for Sanofi SA is SAN:xpar. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
Sanofi SA has its primary listing on Euronext Paris. You can trade Sanofi SA with a Saxo account, alongside thousands of other stocks worldwide.
Yes, Sanofi SA is available to trade on SaxoInvestor and SaxoTrader. You can buy shares directly and include Sanofi SA as part of a broader investment portfolio.